Regentis Biomaterials Ltd. Share Price
AMEX: RGNTRegentis Biomaterials Ltd. Stock Performance
Regentis Biomaterials Ltd. Share Price Today
As of 31 October 2026, Regentis Biomaterials Ltd.'s share price is $1.35. The stock opened at $1.35, compared to its previous close of $1.41. During today's trading session, Regentis Biomaterials Ltd.'s share price traded between $1.35 and $1.35, with an average price of $1.35. Over the past 52 weeks, the stock has recorded a high of $15.40 and a low of $1.26. In terms of performance, Regentis Biomaterials Ltd.'s share price has declined by 53.45% over the last six months and is down 80.15% on a year-on-year basis.
Regentis Biomaterials Ltd. Share Price Chart
Regentis Biomaterials Ltd. Annual Profit & Loss
All figures in USD
About Regentis Biomaterials Ltd.
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.
Regentis Biomaterials Ltd. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.85 | $1.35 | -28.95% |
Sep 2026 | $2.03 | $1.90 | -9.52% |
Aug 2026 | $1.73 | $2.10 | +20.69% |
Jul 2026 | $3.57 | $1.74 | -49.71% |
Jun 2026 | $1.69 | $3.46 | +60.19% |
May 2026 | $2.70 | $2.16 | -25.52% |
Apr 2026 | $3.11 | $2.90 | -7.64% |
Mar 2026 | $3.01 | $3.14 | -21.30% |
Feb 2026 | $4.77 | $3.99 | -37.75% |
Jan 2026 | $7.00 | $6.41 | -5.74% |
Dec 2025 | $7.40 | $6.80 | N/A |